Nitrogen

Description

Nitrogen Refrigerated Liquid NF is classified as a non-flammable gas and is designated under UN 1977. The product is supplied in a container that must always be kept in an upright position. It is intended for use under prescription only, as indicated by the warning label. The specific contents and lot number are to be filled in as applicable. For safety and product information, it is essential to refer to the Material Safety Data Sheet. In the event of inhalation, the individual should be removed to fresh air, and if not breathing, artificial respiration should be administered. If breathing difficulties occur, oxygen should be provided, and a physician should be contacted. In cases of frostbite, immediate medical treatment is necessary. The product is manufactured by Ratermann MFG Inc., and inquiries can be directed to 925-606-2949.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.

There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider the absence of these effects when evaluating treatment options for their patients.

Dosage and Administration

Administration of nitrogen is associated with potential hazards and may be contraindicated in certain situations. It is imperative that nitrogen is used solely by or under the supervision of a licensed practitioner who possesses experience in its use and administration. Practitioners must be thoroughly familiar with the indications, effects, dosages, methods, frequency, and duration of administration prior to initiating treatment.

Nitrogen is administered via the respiratory route through inhalation. The active ingredient is nitrogen, with a strength of 99 L in 100 L. Careful consideration should be given to the specific circumstances of each patient to ensure safe and effective use.

Contraindications

Administration of nitrogen is contraindicated in patients who are not under the supervision of a licensed practitioner experienced in its use. Due to the potential hazards associated with nitrogen, it should only be administered by individuals familiar with its indications, effects, dosages, methods, frequency, duration, and associated risks.

Additionally, the use of nitrogen is contraindicated in situations where liquid nitrogen may come into contact with eyes, skin, or clothing, as this can result in severe injury. It is imperative to avoid dropping the container and to utilize a hand truck for movement. The valve must be closed after each use and when the container is empty to prevent accidental release.

Warnings and Precautions

Administration of nitrogen may pose significant risks and is contraindicated in certain situations. It is imperative that nitrogen is used solely by or under the supervision of a licensed practitioner who possesses expertise in its use and administration. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Nitrogen exists in extremely cold liquid form and as a gas under pressure, which can lead to rapid suffocation and severe frostbite if not handled properly. It is essential to store and utilize nitrogen in environments with adequate ventilation to mitigate these risks. Direct contact with the liquid nitrogen should be avoided; it must not come into contact with the eyes, skin, or clothing. When withdrawing liquid nitrogen, appropriate personal protective equipment, including a face shield and gloves, should be worn to prevent injury.

Furthermore, care must be taken to avoid dropping nitrogen containers. A hand truck should be employed for the movement of these containers to ensure safety. After each use and when the container is empty, the valve should be securely closed. All handling and usage of nitrogen must be conducted in accordance with the Material Safety Data Sheet (MSDS) to ensure compliance with safety protocols and to minimize potential hazards.

Side Effects

Administration of nitrogen may pose significant hazards, including contraindications in certain patient populations. The use of extremely cold liquid and gas under pressure can lead to rapid suffocation and severe frostbite if not handled properly. It is critical that patients and healthcare providers are aware of the potential for these serious adverse reactions.

In clinical settings, precautions must be taken to prevent contact with liquid nitrogen, as exposure can result in severe injury. Patients should be advised to avoid getting liquid nitrogen in their eyes, on their skin, or on clothing. During liquid withdrawal, it is essential for personnel to wear appropriate protective equipment, including a face shield and gloves, to mitigate the risk of injury.

Furthermore, the handling of nitrogen containers requires careful attention to safety protocols. Containers should not be dropped, and a hand truck should be utilized for movement to prevent accidents. After each use and when the container is empty, the valve should be closed to ensure safety. All procedures should be conducted in accordance with the Material Safety Data Sheet (MSDS) to minimize the risk of adverse reactions associated with nitrogen administration.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

There is no specific pediatric use information available for this medication, including recommended ages, dosing differences, safety concerns, or special precautions for children. Healthcare professionals should exercise caution when considering the use of this medication in pediatric patients due to the absence of relevant data.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The administration of nitrogen during pregnancy may pose potential risks, and its use is generally considered hazardous or contraindicated. There is no specific information available regarding the safety of nitrogen use in pregnant patients, including any associated fetal outcomes or necessary dosage modifications. Therefore, it is crucial that nitrogen is used only by or under the supervision of a licensed practitioner who has experience in its administration. Healthcare professionals should exercise caution and consider the lack of data when advising women of childbearing potential regarding the use of nitrogen during pregnancy.

Lactation

The safety and effectiveness of nitrogen in lactating mothers have not been established. Caution should be exercised when administering nitrogen to nursing mothers due to the potential for excretion in breast milk. It is important to consider the risks and benefits before administering nitrogen to this population.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should inform patients that this drug has not been found by the FDA to be safe and effective, and that this labeling has not been approved by the FDA. It is essential to emphasize that this product is available by prescription only.

Providers should advise patients to refer to the Material Safety Data Sheet (MSDS) for comprehensive safety and product information. In the event of inhalation, patients should be instructed to move to fresh air immediately. If the patient is not breathing, artificial respiration should be administered, and if breathing is difficult, oxygen should be provided. It is crucial to call a physician in such situations.

Patients should be made aware of the risks associated with frostbite and the importance of obtaining medical treatment immediately if such an incident occurs. The administration of nitrogen may pose hazards or be contraindicated, and therefore, it should only be used by or under the supervision of a licensed practitioner who is experienced in its use and administration. This practitioner should be familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the hazards, contraindications, side effects, and necessary precautions.

Healthcare providers should also communicate that the product is extremely cold, exists as a liquid and gas under pressure, and can cause rapid suffocation and severe frostbite. Patients should be instructed to store and use the product with adequate ventilation and to avoid contact with eyes, skin, or clothing. For liquid withdrawal, it is recommended that patients wear a face shield and gloves.

Additionally, patients should be cautioned against dropping the container and should use a hand truck for movement. It is important to close the valve after each use and when the container is empty, and to always use the product in accordance with the MSDS.

Storage and Handling

The product is supplied in containers that must always be kept in an upright position to ensure safety and integrity. It is essential to store and use the product in an area with adequate ventilation to minimize exposure to vapors. Care should be taken to avoid contact with eyes, skin, or clothing, as the liquid can cause irritation.

For liquid withdrawal, it is recommended that personnel wear a face shield and gloves to protect against accidental splashes. Containers should not be dropped; instead, a hand truck should be utilized for safe movement. After each use and when the container is empty, the valve must be closed to prevent leaks and ensure safety.

All handling and usage should be conducted in accordance with the Material Safety Data Sheet (MSDS) to ensure compliance with safety protocols.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by Bill Munn Supply Inc, dba Munn Supply. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)